Investment Thesis
Balchem demonstrates solid operational performance with 8.8% revenue growth and impressive 20.9% EPS growth, supported by healthy margins (20.5% operating, 14.9% net) and a fortress balance sheet. However, return on equity of just 3.1% and ROA of 2.4% reveal severe capital efficiency challenges—the company generates adequate accounting profits but converts only 5.3% to free cash flow, indicating capital-intensive operations with suboptimal returns on deployed capital.
Strengths
- Strong revenue growth of 8.8% YoY with excellent EPS growth of 20.9%
- Healthy operating and net margins (20.5% and 14.9%) demonstrating competitive positioning and cost control
- Fortress balance sheet with conservative leverage (0.12x Debt/Equity) and strong liquidity (2.55x current ratio)
- Excellent interest coverage ratio of 9.4x providing financial stability
Risks
- Critically low return on equity (3.1%) and ROA (2.4%) indicate severe capital inefficiency relative to peer benchmarks
- Significant disconnect between net margin (14.9%) and FCF margin (5.3%) reveals high capital intensity and working capital requirements
- Capital expenditure consumes 64% of operating cash flow, limiting financial flexibility and shareholder returns
Key Metrics to Watch
- Return on Equity trajectory—must improve above 8%+ to justify capital deployment
- Free Cash Flow margin expansion—current 5.3% is unsustainably low relative to net margins
- Capital intensity ratio (CapEx as % of revenue)—indicates whether efficiency is improving
- Asset turnover and working capital management—key drivers of capital return improvement
Financial Metrics
Revenue
270.7M
Net Income
40.3M
EPS (Diluted)
$1.25
Free Cash Flow
14.2M
Total Assets
1.7B
Cash
72.9M
Profitability Ratios
Gross Margin
37.3%
Operating Margin
20.5%
Net Margin
14.9%
ROE
3.1%
ROA
2.4%
FCF Margin
5.3%
Balance Sheet & Liquidity
Current Ratio
2.55x
Quick Ratio
1.59x
Debt/Equity
0.12x
Debt/Assets
24.1%
Interest Coverage
9.36x
Long-term Debt
156.0M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-06T11:36:28.730318 |
Data as of: 2026-03-31 |
Powered by Claude AI